Members |
targetComponentId |
Acute female pelvic peritonitis |
Pelvic peritonitis |
Acute female pelvic peritonitis |
Pelvic peritonitis |
Acute gouty arthritis |
Primary gout |
Acute idiopathic thrombocytopenic purpura |
Autoimmune thrombocytopenia (disorder) |
Acute ill-defined cerebrovascular disease |
Cerebrovascular disease |
Acute leukemia - category |
Acute leukemia |
Acute lymphangitis of back, except buttock |
Acute lymphangitis of back |
Acute lymphangitis of foot, except toe |
Acute lymphangitis of foot |
Acute lymphangitis of head, except face |
Acute lymphangitis of head |
Acute lymphangitis of other specified site |
Acute lymphangitis |
Acute lymphoblastic leukemia |
Precursor cell lymphoblastic leukemia |
Acute lymphoblastic leukemia - category |
Precursor cell lymphoblastic leukemia |
Acute lymphoblastic leukemia, L2 type |
Precursor cell lymphoblastic leukemia |
Acute mastoiditis with other complications |
Acute mastoiditis with complication |
Acute monoblastic and monocytic leukemia |
Acute monocytic leukemia |
Acute monoblastic leukemia |
Acute monocytic leukemia |
Acute monoblastic leukemia in remission |
Acute monocytic leukemia in remission |
Acute monocytic leukemia, FAB M5 |
Acute monocytic leukemia |
Acute monocytic/monoblastic leukemia |
Acute monocytic leukemia |
Acute myelogenous leukemia with maturation, FAB M2 |
Acute myeloid leukemia with maturation, FAB M2 |
Acute myeloid leukemia - category |
Acute myeloid leukemia (morphologic abnormality) |
Acute myeloid leukemia due to recurrent genetic abnormality |
Acute myeloid leukemia, disease |
Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation |
Acute myeloid leukemia, disease |
Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation |
Acute myeloid leukemia (morphologic abnormality) |
Acute myeloid leukemia with multilineage dysplasia following a myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disorder |
Acute myeloid leukemia (morphologic abnormality) |
Acute myeloid leukemia with multilineage dysplasia without antecedent myelodysplastic syndrome |
Acute myeloid leukemia (morphologic abnormality) |
Acute myeloid leukemia with mutated RUNX1 |
Acute myeloid leukemia with RUNX1::RUNX1T1 fusion |
Acute myeloid leukemia with recurrent genetic abnormality |
Acute myeloid leukemia (morphologic abnormality) |
Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL |
Acute myeloid leukemia with KMT2A rearrangement (morphologic abnormality) |
Acute myeloid leukemia, no International Classification of Diseases for Oncology subtype |
Acute myeloid leukemia (morphologic abnormality) |
Acute myelomonocytic leukemia - eosinophilic variant |
Acute myeloid leukemia with CBFB::MYH11 fusion (disorder) |
Acute myoendocarditis NOS |
Acute myoendocarditis |
Acute necrotizing encephalitis, NEC |
Acute necrotizing encephalitis |
Acute non-A non-B hepatitis |
Acute viral hepatitis |
Acute non-A, non-B, non-C hepatitis |
Acute viral hepatitis |
Acute parametritis and pelvic cellulitis |
Acute pelvic inflammatory disease |
Acute pelvic cellulitis |
Acute pelvic inflammatory disease |
Acute pharyngitis, NOS |
Acute pharyngitis |
Acute polyarticular juvenile rheumatoid arthritis |
Acute polyarticular juvenile idiopathic arthritis (disorder) |
Acute polyarticular juvenile rheumatoid arthritis |
Acute polyarticular juvenile idiopathic arthritis (disorder) |
Acute pulmonary edema |
Acute pulmonary edema |
Acute reaction to foreign substance left during procedure NOS |
Acute reaction to foreign substance left during procedure |
Acute renal failure due to obstruction |
Post-renal acute kidney injury |
Acute respiratory distress, NEC |
Acute respiratory distress (finding) |
Acute rheumatic heart disease, NOS |
Acute rheumatic heart disease |
Acute suppurative otitis media due to another disease |
Acute suppurative otitis media |
Acute yellow atrophy of liver during pregnancy |
Necrosis of liver of pregnancy |
Acyclovir 200mg dispersible tablet |
Aciclovir 200 mg oral tablet |
Acyclovir 400mg dispersible tablet |
Aciclovir 400 mg oral tablet |
Acyclovir 800mg dispersible tablet |
Aciclovir 800 mg oral tablet |
Addiction |
Addiction |
Addison's disease, NOS |
Addison's disease |
Additional general conditions of patient |
Clinical finding (finding) |
Additional preoperative procedure instituted by anesthetist |
Preoperative procedure |
Additional preoperative therapy instituted by anesthetist |
Preoperative procedure |
Adductor digiti minimi muscle of hand |
Structure of abductor digiti minimi muscle of hand (body structure) |
Adenocarcinoid tumor |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
Adenocarcinoid tumour |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
Adenocarcinoma and squamous carcinoma histologic grade |
Histologic grade of neoplasm (observable entity) |
Adenocarcinoma, no subtype |
Adenocarcinoma (morphologic abnormality) |
Adenocarcinoma, no subtype, high grade |
High grade adenocarcinoma (morphologic abnormality) |
Adenocarcinoma, no subtype, intermediate grade |
Intermediate grade adenocarcinoma (morphologic abnormality) |
Adenocarcinoma, no subtype, low grade |
Low grade adenocarcinoma (morphologic abnormality) |
Adenofibroma, no International Classification of Diseases for Oncology subtype |
Benign adenofibroma (morphologic abnormality) |
Adenoma, no subtype |
Adenoma (morphologic abnormality) |
Adenosine 3mg/mL infusion solution 10mL vial |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Adhesiolysis - action |
Dissection - action |
Adie's pupil |
Tonic pupillary reaction |
Adjustment of external splintage |
Adjusting of splint |
Adjustment reaction in infancy |
Adjustment reaction in infancy (disorder) |
Adjustment reaction of adolescence |
Adjustment reaction of adolescence (disorder) |
Adjustment reaction of adult life |
Adjustment reaction of adult life (disorder) |
Adjustment reaction of childhood |
Adjustment reaction of childhood (disorder) |
Adjustment reaction of late life |
Adjustment reaction of late life (disorder) |
Adjustment to prosthesis in organ NOC |
Prosthetic readjustment |
Administration |
Introduction procedure (procedure) |
Administration |
Introduction procedure (procedure) |
Administration |
Introduction procedure (procedure) |
Administration |
Introduction procedure (procedure) |
Administration of RhD immune globulin |
Administration of human anti-D immunoglobulin (procedure) |
Administration of RhD immune globulin declined |
Administration of human anti-D immunoglobulin declined |
Administration of prescribed medications and solutions |
Administration of medication |
Administration of prescribed medications based on arterial blood gas results |
Administration of medication |
Administration of skin test by nurse |
Skin test |
Administration of substance |
Introduction procedure (procedure) |
Administration of substance by intravenous piggyback |
Administration via intravenous route (procedure) |
Administration of substance into bladder via intravesical route |
Administration into urinary bladder via intravesical route |
Administration of substance via enteral route |
Administration via enteral route (procedure) |
Administration of substance via gastroenteral route |
Administration via gastroenteral route |
Administration of substance via intraarterial route |
Administration via intraarterial route |
Administration of substance via intravenous route |
Administration via intravenous route (procedure) |
Administration of substance via oral route |
Administration via oral route (procedure) |
Administration of substance via specific route |
Administration via specific route |
Administration of substance via subcutaneous route |
Administration via subcutaneous route |
Administration of substance via topical route |
Administration via topical route |
Administration of substance via vaginal route |
Medication administration: vaginal |
Administration of syntometrine |
Administration of ergometrine and oxytocin |
Administration of therapeutic medication |
Administration of medication |
Administration of therapeutic substance |
Administration of medication |
Administration of therapeutic substance |
Administration of medication |
Administration of therapeutic substance into artery |
Administration via intraarterial route |